$TOI
Oncology Institute, Inc. Stock $toi

$toi Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000179919124000022 Filed on August 13, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$99.90M	$98.58M
YoY Change	21.78%	22.88%
Cost Of Revenue	$85.54M	$85.55M
YoY Change	29.48%	31.4%
Gross Profit	$14.37M	$13.03M
YoY Change	-10.1%	-13.83%
Gross Profit Margin	14.38%	13.21%
Selling, General & Admin	$26.65M	$27.87M
YoY Change	-5.53%	-2.97%
% of Gross Profit	185.48%	213.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$800.0K	$745.0K
YoY Change	-12.47%	23.96%
% of Gross Profit	5.57%	5.72%
Operating Expenses	$26.65M	$27.87M
YoY Change	-5.53%	-2.97%
Operating Profit	-$13.85M	-$16.36M
YoY Change	-0.52%	9.55%
Interest Expense	-$2.225M	-$2.118M
YoY Change	26.42%	29.3%
% of Operating Profit
Other Income/Expense, Net	-$2.260M	$885.0K
YoY Change	-32.72%	-147.58%
Pretax Income	-$16.11M	-$15.48M
YoY Change	-6.78%	-7.85%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$16.11M	-$15.48M
YoY Change	-7.5%	-8.39%
Net Earnings / Revenue	-16.13%	-15.7%
Basic Earnings Per Share	-$0.18	-$0.17
Diluted Earnings Per Share	-$0.18	-$0.17
COMMON SHARES
Basic Shares Outstanding	75.49M shares	74.44M shares
Diluted Shares Outstanding	75.52M shares	74.75M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.40M	$46.36M
YoY Change	-45.76%	18.32%
Cash & Equivalents	$47.40M	$36.42M
Short-Term Investments	$0.00	$9.939M
Other Short-Term Assets	$4.057M	$4.157M
YoY Change	-3.4%	-28.66%
Inventory	$10.11M	$11.32M
Prepaid Expenses
Receivables	$54.50M	$54.02M
Other Receivables	$358.0K	$350.0K
Total Short-Term Assets	$116.4M	$116.2M
YoY Change	-23.75%	11.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.27M	$12.23M
YoY Change	13.79%	13.55%
Goodwill	$7.230M	$7.230M
YoY Change	0.0%	0.0%
Intangibles	$15.58M	$16.36M
YoY Change	-16.04%	-15.44%
Long-Term Investments
YoY Change
Other Assets	$588.0K	$582.0K
YoY Change	5.0%	4.49%
Total Long-Term Assets	$62.76M	$63.39M
YoY Change	-4.44%	-49.64%
TOTAL ASSETS
Total Short-Term Assets	$116.4M	$116.2M
Total Long-Term Assets	$62.76M	$63.39M
Total Assets	$179.2M	$179.6M
YoY Change	-17.94%	-21.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$24.57M	$15.75M
YoY Change	84.29%	20.02%
Accrued Expenses	$15.44M	$12.83M
YoY Change	21.32%	-9.17%
Deferred Revenue	$1.382M	$861.0K
YoY Change	153.58%	41.15%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$46.76M	$35.10M
YoY Change	44.36%	4.76%
LONG-TERM LIABILITIES
Long-Term Debt	$91.54M	$89.95M
YoY Change	7.37%	7.48%
Other Long-Term Liabilities	$133.0K	$179.0K
YoY Change	-71.02%	-67.63%
Total Long-Term Liabilities	$91.67M	$90.13M
YoY Change	6.95%	6.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$46.76M	$35.10M
Total Long-Term Liabilities	$91.67M	$90.13M
Total Liabilities	$163.7M	$150.4M
YoY Change	11.74%	3.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$197.6M	-$181.5M
YoY Change	55.13%	65.05%
Common Stock	$8.000K	$8.000K
YoY Change	0.0%	14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.48M	$29.21M
YoY Change
Total Liabilities & Shareholders Equity	$179.2M	$179.6M
YoY Change	-17.94%	-21.9%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$16.11M	-$15.48M
YoY Change	-7.5%	-8.39%
Depreciation, Depletion And Amortization	$800.0K	$745.0K
YoY Change	-12.47%	23.96%
Cash From Operating Activities	$819.0K	-$15.66M
YoY Change	-109.86%	80.83%
INVESTING ACTIVITIES
Capital Expenditures	-$402.0K	$1.826M
YoY Change	-143.23%	94.88%
Acquisitions
YoY Change
Other Investing Activities	$10.00M	$20.00M
YoY Change	15.74%	-22.59%
Cash From Investing Activities	$10.40M	$18.18M
YoY Change	34.92%	-27.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-243.0K	-2.147M
YoY Change	-68.03%	-17.45%
NET CHANGE
Cash From Operating Activities	819.0K	-15.66M
Cash From Investing Activities	10.40M	18.18M
Cash From Financing Activities	-243.0K	-2.147M
Net Change In Cash	10.98M	369.0K
YoY Change	-907.21%	-97.3%
FREE CASH FLOW
Cash From Operating Activities	$819.0K	-$15.66M
Capital Expenditures	-$402.0K	$1.826M
Free Cash Flow	$1.221M	-$17.49M
YoY Change	-113.21%	82.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	123175000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8095000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7596000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	39000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6280000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	29000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4268000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherReceivablesNetCurrent
CY2024Q2	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherReceivablesNetCurrent
CY2024Q2	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#MarketableSecuritiesCurrent
CY2023Q4	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#MarketableSecuritiesCurrent
CY2024Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityCurrent
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	143000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-46895000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73786374	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73786374	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	57025000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-19889000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	73000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4087000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	41296000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-15479000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3387000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	29206000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-29998000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5229000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	98406000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-16897000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4107000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	894000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	84722000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35368000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-46895000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3007000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2598000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3124000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3067000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16867000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7474000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	9072000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-552000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-261000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-769000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2568000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3318000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	121000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-113000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	451000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1589000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-30000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-2000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-50000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11657000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6576000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-201000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-118000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2356000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2907000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	108000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1091000	usd
	toi	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-2177000	usd
	toi	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-3125000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	21000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	80000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	898000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3751000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1793000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2529000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1976000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1350000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-167000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-320000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31543000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24112000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2436000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2776000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4300000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	9747000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	40000000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	60127000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	37564000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	43304000	usd
	toi	Payments For Financing Of Insurance Payments PaymentsForFinancingOfInsurancePayments	1002000	usd
	toi	Payments For Financing Of Insurance Payments PaymentsForFinancingOfInsurancePayments	2576000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2140000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	759000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	18000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	81000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	894000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3085000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4310000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2936000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	14882000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33488000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14010000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36424000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28892000	usd
	toi	Deferred Consideration As Part Of Practice Acquisitions DeferredConsiderationAsPartOfPracticeAcquisitions	0	usd
	toi	Deferred Consideration As Part Of Practice Acquisitions DeferredConsiderationAsPartOfPracticeAcquisitions	1813000	usd
	toi	Purchases Of Property Plant And Equipment Included In Accounts Payable PurchasesOfPropertyPlantAndEquipmentIncludedInAccountsPayable	423000	usd
	toi	Purchases Of Property Plant And Equipment Included In Accounts Payable PurchasesOfPropertyPlantAndEquipmentIncludedInAccountsPayable	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	170000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2224000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2255000	usd
	toi	Number Of Oncologists And Mid Level Professionals Within Three States Minimum NumberOfOncologistsAndMidLevelProfessionalsWithinThreeStatesMinimum	126	oncologist
	toi	Number Of Clinic Locations NumberOfClinicLocations	73	cliniclocation
CY2024Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	4	state
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates under different assumptions or conditions. Significant items subject to such estimates and assumptions include judgments related to revenue recognition, estimated accounts receivable and the allowance for credit losses, useful lives and recoverability of long-lived and intangible assets, recoverability of goodwill, fair values of acquired identifiable assets and assumed liabilities in business combinations, fair value of intangible assets and goodwill, fair value of share-based compensation, fair value of liability classified instruments, and judgments related to deferred income taxes.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June 30, 2024, due to historical Direct and Indirect Remuneration (DIR) fee run out data and low reimbursement, the Company changed its estimates for DIR fees incurred. The result of this change in estimate resulted in a decrease to the dispensary operating revenue segment and net income by approximately $2.4 million for the three and six months ended June 30, 2024.</span></div>
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16867000	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16867000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	54017000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	42360000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q1	toi	Accounts Receivable After Allowance For Credit Loss Remaining Amount AccountsReceivableAfterAllowanceForCreditLossRemainingAmount	39816000	usd
	toi	Accounts Receivable Allowance For Credit Loss Recovery Reversal AccountsReceivableAllowanceForCreditLossRecoveryReversal	0	usd
CY2024Q2	toi	Accounts Receivable Allowance For Credit Loss Recovery Reversal AccountsReceivableAllowanceForCreditLossRecoveryReversal	0	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	11000	usd
CY2023Q2	toi	Accounts Receivable Allowance For Credit Loss Recovery Reversal AccountsReceivableAllowanceForCreditLossRecoveryReversal	3000	usd
	toi	Accounts Receivable Allowance For Credit Loss Recovery Reversal AccountsReceivableAllowanceForCreditLossRecoveryReversal	13000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98578000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	80224000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	193244000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	156416000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	861000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	545000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1139000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	489000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	529000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	11322000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	13678000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	34875000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	16000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	34859000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	72279000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	134000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	72150000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	34859000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0	usd
CY2024Q2	toi	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year5 DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYear5	0	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	34859000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	72150000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0	usd
CY2023Q4	toi	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year5 DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYear5	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	72150000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-34000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	121000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	1	security
CY2024Q2	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	42000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	242000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	24920000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7626000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6180000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12232000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10883000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	745000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	601000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5155000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5518000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	861000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	545000	usd
CY2024Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	0	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	1002000	usd
CY2024Q2	toi	Business Combination Consideration Transferred Other Current BusinessCombinationConsiderationTransferredOtherCurrent	331000	usd
CY2023Q4	toi	Business Combination Consideration Transferred Other Current BusinessCombinationConsiderationTransferredOtherCurrent	2206000	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1124000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1124000	usd
CY2024Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	5360000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	3601000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12831000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	13996000	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	1250000	usd
CY2023Q4	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.0875
CY2023Q4	toi	Number Of Instalments Payable NumberOfInstalmentsPayable	10	installment
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	122000	usd
CY2023Q4	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	1002000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1995000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1838000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	10000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	18000	usd
CY2024Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3000	usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	424000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	308000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4147000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	24000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	42000	usd
CY2024Q2	toi	Lessee Operating Lease Liability To Be Paid Thereafter LesseeOperatingLeaseLiabilityToBePaidThereafter	6427000	usd
CY2024Q2	toi	Finance Lease Liability To Be Paid Thereafter FinanceLeaseLiabilityToBePaidThereafter	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	36813000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	134000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5757000	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	12000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	31056000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	122000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6521000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	41000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24535000	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	81000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	31056000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	122000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y11M19D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y7M13D
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y21D
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M23D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0656
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0622
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0653
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0643
	us-gaap	Operating Lease Payments OperatingLeasePayments	4143000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3448000	usd
	toi	Repayments For Finance Lease RepaymentsForFinanceLease	24000	usd
	toi	Repayments For Finance Lease RepaymentsForFinanceLease	39000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	783000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7593000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	3000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	110000000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	110000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000	usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-143000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0031
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77224263	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75490489	shares
	toi	Common Stock Votes Per Share CommonStockVotesPerShare	1	vote
	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	163510	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	165045	shares
CY2024Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	100	shares
CY2024Q2	toi	Preferred Stock Maximum Percent Of Common Stock Allowed PreferredStockMaximumPercentOfCommonStockAllowed	0.049
CY2021Q4	toi	Class Of Warrant Or Right Threshold Number Of Business Days Before Sending Notice Of Redemption To Warrant Holders ClassOfWarrantOrRightThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders	3	d
CY2023Q2	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	5000000	shares
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	894000	usd
CY2023Q3	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	2000000	shares
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	125000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	427000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	433000	usd
CY2023	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	2	businesscombination
	toi	Number Of Asset Acquired NumberOfAssetAcquired	0	assetacquisition
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32032000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15675000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16357000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32032000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14128000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17904000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1547000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3091000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3060000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2933000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2828000	usd
CY2024Q2	toi	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	2898000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16357000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	773000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	728000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	7230000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7230000	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	7230000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	21418000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2679000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16867000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	7230000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7230000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-15479000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-16897000	usd
CY2024Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-15479000	usd
CY2023Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-16897000	usd
CY2024Q2	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	-2800000	usd
CY2023Q2	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	-3077000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12679000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13820000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74748365	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74119910	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-15479000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-16897000	usd
CY2024Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-15479000	usd
CY2023Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-16897000	usd
CY2024Q2	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	-2800000	usd
CY2023Q2	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	-3077000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12679000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13820000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74748365	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74119910	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74748365	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74119910	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-16364000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-14938000	usd
CY2024Q2	us-gaap	Assets Assets	179602000	usd
CY2023Q4	us-gaap	Assets Assets	209240000	usd
CY2024Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	143000	usd
CY2023Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	108000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001799191-24-000022-index-headers.html	Edgar Link	pending
0001799191-24-000022-index.html	Edgar Link	pending
0001799191-24-000022.txt	Edgar Link	pending
0001799191-24-000022-xbrl.zip	Edgar Link	pending
ex311-certificationrule13a.htm	Edgar Link	pending
ex312-certificationrule13a.htm	Edgar Link	pending
ex321-ceocertificationsect.htm	Edgar Link	pending
ex322-cfocertificationsect.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
toi-20240630.htm	Edgar Link	pending
toi-20240630.xsd	Edgar Link	pending
toi-20240630_def.xml	Edgar Link	unprocessable
toi-20240630_lab.xml	Edgar Link	unprocessable
toi-20240630_pre.xml	Edgar Link	unprocessable
toi-20240630_htm.xml	Edgar Link	completed
toi-20240630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TOI
Oncology Institute, Inc. Stock $toi

2024 Q3 Form 10-Q Financial Statement

#000179919124000022 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TOI Oncology Institute, Inc. Stock $toi

2024 Q3 Form 10-Q Financial Statement

#000179919124000022 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TOI
Oncology Institute, Inc. Stock $toi